|
Merck & Co. News is an EIN News Service for pharmaceuticals professionals. Constantly updated news and information about pharmaceuticals.
- DRUGMAKERS IN 'GOLDEN ERA' OF VACCINE PRODUCTION 22 Nov 2009 03:51 GMT
... -- is gunning to become the world's top vaccine manufacturer by revenue, unseating pioneer Merck Co. This spring, Glaxo opened a state-of-the-art vaccine packaging plant in Marietta, Pa., west of Philadelphia, ...
- FACTBOX-Winners, losers in U.S. Senate health bill 22 Nov 2009 04:30 GMT
... billion annual industry fee to be parceled out among companies such as Pfizer Inc, Merck & Co Inc and others. Wider insurance coverage could help offset the industry's costs by providing more ...
- Vaccines getting a boost 22 Nov 2009 05:40 GMT
... GlaxoSmithKline is gunning to become the world's top vaccine manufacturer by revenue, unseating pioneer Merck & Co. This spring, Glaxo opened a state-of-the-art vaccine packaging plant in Marietta, Pa., west of Philadelphia, ...
- Vaccines on horizon for AIDS, Alzheimer's, herpes 22 Nov 2009 05:54 GMT
... Britain is gunning to become the world's top vaccine manufacturer by revenue, unseating pioneer Merck & Co. This past spring, Glaxo opened a state-of-the-art vaccine packaging plant in Marietta, Pa., west of ...
- Vaccines could be on horizon for AIDS, Alzheimer's, herpes 22 Nov 2009 06:31 GMT
... GlaxoSmithKline is gunning to become the world's top vaccine manufacturer by revenue, unseating pioneer Merck & Co. This spring, Glaxo opened a state-of-the-art vaccine packaging plant in Marietta, Pa., west of Philadelphia, ...
- A shot in the arm 22 Nov 2009 07:51 GMT
... GlaxoSmithKline is gunning to become the world’s top vaccine manufacturer by revenue, unseating pioneer Merck & Co. This spring, Glaxo opened a state-of-the-art vaccine packaging plant in Marietta, Pa., west of Philadelphia, ...
- NicOx announces FDA accepts naproxcinod NDA for filing 22 Nov 2009 16:15 GMT
... several nitric oxide- donating NCEs, which are in development internally and with partners, including Merck & Co., Inc., for the treatment of widespread eye diseases, cardiometabolic diseases, hypertension, respiratory disorders and ...
- Healthcare reform faces challenges in U.S. Senate 22 Nov 2009 19:00 GMT
... said on "Meet the Press" on Sunday. Pharmaceutical companies such as Pfizer Inc and Merck & Co Inc and business groups are opposing the "public option." Drugmakers, business groups and insurers such ...
- WRAPUP 1-Healthcare reform faces challenges in U.S. Senate 22 Nov 2009 19:03 GMT
... WASHINGTON, Nov 22 (Reuters) - President Barack Obama's U.S. healthcare overhaul plan has cleared an important ...
- WRAPUP 2-Healthcare reform faces challenges in U.S. Senate 22 Nov 2009 20:13 GMT
... WASHINGTON, Nov 22 (Reuters) - President Barack Obama's U.S. healthcare overhaul plan has cleared an important ...
- Healthcare reform faces challenges in US Senate 22 Nov 2009 20:15 GMT
... "It has been," Mr Durbin said on Pharmaceutical companies such as Pfizer Inc and Merck & Co Inc and business groups are opposing the "public option." Drugmakers, business groups and insurers such ...
- New research: Commercial Insight: Antidiabetics - DPP-IV inhibitors poised to sweep the market 22 Nov 2009 20:51 GMT
... Product positioning 157 SWOT analysis 158 Brand forecast to 2018 160 Januvia franchise (sitagliptin; Merck & Co) 162 Drug profile 162 Franchise overview 163 Product positioning 167 SWOT analysis 169 Brand forecast ...
- Healthcare reform faces challenges in Senate 22 Nov 2009 21:20 GMT
... bill will collapse of its own weight." Pharmaceutical companies such as Pfizer Inc and Merck & Co Inc and insurers such as UnitedHealth Group Inc and WellPoint Inc> are spending hundreds of ...
- S&P: Merck & Co. Inc. New 4(2) Commercial Paper Program Assigned 'A-1+' Rating; 'AA-' Corporate Credit Rating Affirmed 17 Nov 2009 16:11 GMT
... S&P: Merck & Co. Inc. New 4(2) Commercial Paper Program Assigned 'A-1+' Rating; 'AA-' Corporate Credit Rating Affirmed --U.S. ...
- BRIEF-Moody's rates Merck & Co new commercial paper program P-1 17 Nov 2009 22:14 GMT
... rates Merck&Co Inc new commercial paper program P-1 Copyright Thomson Reuters 2009. All rights reserved. The ...
Powered by 
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
- GlaxoSmithKline to Market Nicotine Vaccine [22 Nov 2009 - 21:12]
- PRIMECAP Management Top Purchases: Amgen Inc., The Boeing Company, Telefonaktiebolaget LM Ericsson Telephone Company, Electronic Arts Inc., Eli Lilly and Company [22 Nov 2009 - 16:29]
- PRIMECAP Management Top Holdings: Amgen Inc., Eli Lilly and Company, Novartis AG, FedEx Corp., Google Inc., Medtronic Inc. [22 Nov 2009 - 16:29]
- Local, state officials not to blame for Pfizer closures [22 Nov 2009 - 14:28]
- GlaxoSmithKline Takes 'Three-Pronged' Approach in China to Fight H1N1 Flu [22 Nov 2009 - 13:49]
- CDC Reverses Gardasil Vaccine Requirement for Immigrants [21 Nov 2009 - 03:15]
- FDA actions in brief, November 2009 (FluMist, Cervarix, Gardasil, Fluarix, Folotyn, Micardis, Twynsta, Votrient, Mirena) [20 Nov 2009 - 17:02]
- FDA Pipeline preview, October 2009 (Eplivanserin, Pancrelipase, Trabectedin, Clofarabine, Fampridine-SR, Collagenase clostridium histolyticum, Oxycodone reformulated, Pegylated interferon alfa-2b, Maraviroc, Armodafinil, R [20 Nov 2009 - 17:02]
- Pregnancy, not nevirapine cause of liver toxicities in HIV-positive women [20 Nov 2009 - 04:58]
- FDA Approves Gardasil for Genital Warts in Men and Boys [19 Nov 2009 - 16:02]
Pharmaceutical Industry Today
|
a digital news provider
reuters.com:
healthday.com: